1. Blumer JL. Meropenem: evaluation of a new
generation carbapenem. Int J Antimicrob Agents 1997; 8: 73-92.
2. Fish DN, Singletary TJ. Meropenem: A new
carbapenem antibiotic. Pharmacotherapy 1997; 17: 644-669.
3. Drusano GL, Hutchison M. The pharmaco-kinetics
of meropenem. Scand J Infect Dis 1995; 96: 11-16.
4. Kelly HC, Hutchison M, Haworth SJ. A
comparison of the pharmacokinetics of meropenem after administration
by intravenous injection over 5 min and intravenous infusion over 30
min. J Antimicrob Chemother 1995; 36: 35-41.
5. Hikida M, Kawashima K, Yoshida M, Mitsuhashi
S. Inactivation of new carbapenem antibiotics by dehydropeptiase I
from porcine and human renal cortex. J Antimicrob Chemother 1992;
30: 129-134.
6. Fukaswa M, Sumita Y, Harabe ET, et al.
Stability of meropenem and effect of 1b-methylsubstitution on its
stability in the presence of renal dehydropeptidase I. Antimicob
Agents Chemother 1992; 36: 1577-1579.
7. Pfaller MA, Jones RN. A review of the in vitro
activity of meropenem and comparative antimicrobial agents tested
against 30,254 aerobic and anaerobic pathogens isolated worldwide.
Diagn Microbiol Infect Dis 1997; 28: 157-163.
8. Jones RN, Rhomberg PR, Varnam DJ, Mathai D. A
comparison of the antimicrobial activity of meropenem and selected
broad-spectrum antimicrobials tested against multi-drug resistant
Gram-negative bacilli including bacteraemic Salmonella spp.: initial
studies for the MYSTIC program in India. Int J Antimicrob Agents
2002; 20: 426-431.
9. Chang SC, Fang CT, Chen YC, Hsueh PR, Luh KT,
Hsieh WC. In vitro activity of meropenem against common
pathogenic bacteria isolated in Taiwan. Diagn Microbiol Infect Dis
1998; 32: 273-279.
10. Watanabe A, Tokue Y, Takahashi H, Kikuchi T,
Kobayashi T, Gomi K, et al. Comparative in-vitro activity of
carbapenem antibiotics against respiratory pathogens isolated
between 1999 and 2000. J Infect Chemother 2001; 7: 267-271.
11. Huizinga WKJ, Warren BL. Baker LW, Valleur P,
Pezet DM, Hoogkamp-Korstanjep JA, et al. Antibiotic
monotherapy with meropenem in the surgical management of
intraabdominal infections. J Antimicrob Chemother 1995; 36: 179-189.
12. Hamacher J, Vogel F, Lichy J, Kohl FE, Diwok
K, Wender H, et al. Treatment of acute bacterial
exacerbations of chronic obstructive pulmonary disease in
hospitalised patients - a comparison of meropenem and imipenem/cilastatin.
J Antimicrob Chemother 1995; 36: 121-133.
13. Romaneilli G, Cravarezza, P, Italian
Intramuscular Meropenem Study Group. Intramuscular meropenem in the
treatment of bacterial infections of the urinary and lower
respiratory tract. J Antimicrob Chemother 1995; 36: 109-119.
14. Mouton YJ, Beuscart C, Meropenem Study Group.
Empirical monotherapy with meropenem in serious bacterial
infections. J Antimicob Chemother 1995; 36: 145-156.
15. Ayan M, Kuzucu C, Durmaz R, Aktas E, Cizmeci
Z. Analysis of three outbreaks due to Klebsiella species in a
neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;
24: 495-500.
16. Mahmood A, Karamat KA, Butt T. Neonatal
sepsis: high antibiotic resistance of the bacterial pathogens in a
neonatal intensive care unit in Karachi. J Pak Med Assoc 2002; 52:
348-350.
17. Aktas E, Yigit N, Yazgi H, Ayyildiz A.
Detection of antimicrobial resistance and extended-spectrum beta-lactamase
production in Klebsiella pneumoniae strains from infected neonates.
Int Med Res 2002; 30: 445-448.
18. Godula-Stuglik U, Mikusz G. Clinical efficacy
of meropenem in the management of severe nosocomial infections in
neonates. J Antimicrob Chemother 1999; 44: 63-64.
19. Beloborodova NV, Biryukov AV. Using meropenem
("Meronem" Zenca) in neonates. Clin Microbiol Infect 1997; 2: 124.
20. Koksal N, Hacimustafaoglu M, Bagci S, Celebi
S. Meropenem in neonatal severe infections due to multiresistant
gram-negative bacteria. Indian J Pediatr 2001; 68: 15-19.
21. Shah D, Narang M, Faridi MMA. Efficacy and
safety of meropenem in neonatal sepsis. In: Abstracts: 42nd
National Conference of the Indian Academy of Pediatrics; 2005 Jan
6-9; Kolkata, India. p.129.
22. Fleischhack G, Hartmann C, Simon A, Wulff B,
Havers W, Marklein G, et al. Meropenem versus ceftazidime as
empirical monotherapy in febrile neutropenia of paediatric patients
with cancer. J Antimicrob Chemother 2001; 47: 841-853.
23. Arrieta A. Use of meropenem in the treatment
of serious infections in children: review of the current literature.
Clin Infect Dis 1997; 24 (Suppl 2): S207-S212.
24. Hsu HL, Lu CY, Tseng HY, Lee PI, Lai HP, Lin
WC, et al. Empirical monotherapy with meropenem in serious
bacterial infections in children. Microbiol Immunol Infect 2001; 34:
275-280.
25. Hasegawa K, Chiba N, Kobayashi R, Murayama SY,
Iwata S, Sunakawa K, et al. Rapidly increasing prevalence of
beta-lactamase-nonproducing, ampicillin-resistant Haemophilus
influenzae type b in patients with meningitis. Antimicrob Agents
Chemother 2004; 48: 1509-1514.
26. Sonntag J, Kaczmarek D, Brinkmann G, Kammler
G, Hellwege HH. Complicating neonatal Escherichia coli meningitis. Z
Geburtshilfe Neonatol 2004; 208: 32-35.
27. Segal-Maurer S, Mariano N, Qavi A, Urban C,
Rahal JJ Jr. Successful treatment of ceftazidime-resistant
Klebsiella pneumoniae ventriculitis with intravenous meropenem and
intra-ventricular polymyxin B: Case report and review. Clin Infect
Dis 1999; 28: 1134-1138.
28. Paffetti A, D’Aviera L, Le Foche F, Mannozzi
P, Mastropietro C, Croce GF, et al. Successful meropenem
therapy of a brain abscess and meningitis arising from acute
purulent otomastoiditis: Case report. Chemother 1998; 10: 132-135.
29. Hurst M, Lamb HM. Meropenem: a review of its
use in patients in intensive care. Drugs 2000; 59: 653-680.
30. van Enk JG, Touw DJ, Lafeber HN.
Pharmacokinetics of meropenem in preterm neonates. Ther Drug Monit
2001; 23: 198-201.
31. Norrby SR, Gildon KM. Safety profile of
meropenem: a review of nearly 5,000 patients treated with meropenem.
Scand Infect Dis 1999; 31: 3-10.
32. Del Favero A. Clinically important aspects of
carbapenem safety. Curr Opin Infect Dis 1994; 7: S38-S42.
33. Noorby SR, Faulkner KL, Newell PA.
Differentiating meropenem and imipenem/cilastatin. Infect Dis Clin
Pract 1997; 6: 291-303.
34. Navaneeth BV, Sridaran D, Sahay D, Belwadi MR. A preliminary
study on metallo-beta-lactamase producing Pseudomonas aeruginosa in
hospitalized patients. Indian J Med Res 2002; 116: 264-267.